DENTAL DRUGS IN ACTION.

DENTAL DRUGS IN ACTION. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

DENTAL DRUGS IN ACTION. Abstract Text:

W GREENFIELD,

DENTAL DRUGS IN ACTION. Publishing Authors By Initials

W GREENFIELD,

For similar therapeutics: drug therapy research abstracts see: therapeutics: drug therapy research

PUBMED ID PMID:

MEDLINE DATE:

DENTAL DRUGS IN ACTION. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Dental survey

VOLUME: 41

Page Numbers: 59-60

Journal Abbreviation:

ISSN: 0011-8788

DAY: 18

MONTH: Jan

YEAR: 1965

DENTAL DRUGS IN ACTION. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2984744

DENTAL DRUGS IN ACTION. Keywords Mesh Terms:

KEYWORDS: Drug Therapy

MESH TERMS:

Chemical & Substance for Abstract: DENTAL DRUGS IN ACTION. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for DENTAL DRUGS IN ACTION.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Dent Surv

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

DENTAL DRUGS IN ACTION Related Publications

• 'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation.
• A comparative multi-level analysis of contextual drinking in American and Canadian adults.
• A comparison of structural measurements using 2 Stratus optical coherence tomography instruments.
• A foetal plethysmograph.
• A method for measuring the blood flow in the umbilical vessels.
• A multifaceted approach to neuroscience outreach: meeting the challenges.
• Aging and surgeon performance.
• Book reviews.
• Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening.
• Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE study.
• Determination of the folding of proteins as a function of denaturants, osmolytes or ligands using circular dichroism.
• Differential dynamics of transient neuronal assemblies in visual compared to auditory cortex.
• Evaluating quality improvement.
• Factor analysis of the Alcohol and Drug Confrontation Scale (ADCS).
• Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
• Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-alpha production in response to titanium particles in vitro.
• Making another world possible: the Torah, Louis Kelso, and the problem of poverty.
• Molecular basis of tropomyosin binding to tropomodulin, an actin-capping protein.
• Next generation of self-management education: Web-based bipolar disorder program.
• Olivoponto-cerebellar atrophy.
• Part XIII. Systemic antifungal therapy.
• Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
• Recent advances in analytical spectroscopy by K. Fuwa. Pergamon Press, Oxford, 1982, pp. 325, ISBN 0-08-026221 1X, pound42.00.
• Reflections on leukemia and adult stem-cell transplantation: some personal psychological factors.
• Relaxation time, diffusion, and viscosity analysis of model asphalt systems using molecular simulation.
• Scanning laser polarimetry with enhanced corneal compensation and optical coherence tomography in normal and glaucomatous eyes.
• Sexually dimorphic expression of secreted frizzled-related (SFRP) genes in the developing mouse Müllerian duct.
• The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria.
• The relationship of self-esteem and self-efficacy to treatment outcomes of alcohol-dependent men and women.
• Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions.